Immunisation barriers in child-hood

Immunisation is a simple and effective way of protecting children from serious diseases. It not only helps protect individuals, it also protects the broader community by minimising the spread of disease.

Vaccines work by triggering the immune system to fight against certain diseases. If a vaccinated person comes in contact with these diseases, their immune system is able to respond more effectively, preventing the disease from developing or greatly reducing its severity.

Immunisation protects against many serious childhood diseases, including:

• whooping cough (pertussis)
• measles
• German measles (rubella)
• meningococcal C
• pneumococcal disease
• chickenpox (varicella)
• tetanus
• mumps
• polio
• diphtheria
• rotavirus
• Hepatitis.

The National Immunisation Program Schedule recommends certain vaccinations at certain times. Childhood immunisations are recommended at birth, two months (can be given at six weeks), four months, six months, 12 months, 18 months and four years (can be given at 3 years 6 months).

You can obtain the latest schedule information by talking to your immunisation provider, calling 13 HEALTH (13 43 25 84) or visiting Immunisation.

Some children (eg. Aboriginal and Torres Strait Islander children or children with medical risk factors) may require additional vaccines. If you are unsure, check with your doctor or immunisation provider.

Students in Year 8 and Year 10 are also offered recommended vaccines through a school-based program.

Fifteen indicators of potential barriers/facilitators were available, representing: perceived medical contraindications (parents may believe that their child is too ill to be immunised [there are few, extremely rare, genuine contraindications, lack of access to medical services, lack of social support, maternal psychological well being, competing pressures (such as large families) and formal group childcare (at the time of data collection, parents were eligible for childcare assistance if their child was fully immunised, and childcare providers may encourage or require children to be immunised). These variables were dichotomised and entered into a latent class model to identify clusters of barriers within the population.

 Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com